High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

BACKGROUND: Carbonic anhydrase IX (CAIX) is an enzyme upregulated by hypoxia during tumour development and progression. This study was conducted to assess if the expression of CAIX in tumour tissue and/or plasma can be a prognostic factor in patients with non-small cell lung cancer (NSCLC). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: İlie, M, Mazure, N M, Hofman, V, Ammadi, R E, Ortholan, C, Bonnetaud, C, Havet, K, Venissac, N, Mograbi, B, Mouroux, J, Pouysségur, J, Hofman, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883156/
https://www.ncbi.nlm.nih.gov/pubmed/20461082
http://dx.doi.org/10.1038/sj.bjc.6605690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883156/
https://www.ncbi.nlm.nih.gov/pubmed/20461082
http://dx.doi.org/10.1038/sj.bjc.6605690

Ejemplares similares